Greater Cannabis Company, Inc.
Datakwaliteit: 83%
GCAN
OTC
Manufacturing
Chemicals
€ 0,18
€ 0,00
(0,00%)
Marktkapitalisatie: 158.355,0
Prijs
€ 0,18
Marktkapitalisatie
158.355,0
Dagbereik
€ 0,15 — € 0,15
52-Weeksbereik
€ 0,04 — € 3,15
Volume
850
Openen € 0,15
50D / 200D Gem.
€ 0,21
14,82% below
50D / 200D Gem.
€ 0,22
18,60% below
Quick Summary
Belangrijkste Punten
Negative free cash flow of -60.153,0
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio0,02
Interest CoverageN/A
Waardering
PE (TTM)
-0,48
Boven sectorgemiddelde (-1,47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -0,5 | -1,5 |
| P/B | — | 1,6 |
| ROE % | — | -53,5 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -331.612,0 |
| ROE | N/A | ROA | -1379,79% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -60.153,0 |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,02 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | -1,11 M | Tangible Book Value | -1,11 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0,48 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -37,99% | ||
| Market Cap | 158.355,0 | Enterprise Value | 137.000,0 |
| Per Share | |||
| EPS (Diluted TTM) | 0,00 | Revenue / Share | N/A |
| FCF / Share | -0,07 | OCF / Share | -0,07 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 18,14% |
| SBC-Adj. FCF | -61.953 | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | 12.630,0 | 12.630,0 |
| Net Income | -331.612,0 | -179.041,0 | -188.402,0 | -360.268,0 | -602.226,0 |
| EPS (Diluted) | 0,00 | 0,00 | 0,00 | — | — |
| Gross Profit | — | — | — | -25,0 | -25,0 |
| Operating Income | -183.005,0 | -156.276,0 | -175.364,0 | -177.035,0 | -343.146,0 |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Income Tax | — | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 815,0 | 57.785,0 | 172.276,0 | 280.447,0 | 392.937,0 |
| Total Liabilities | 742.464,0 | 898.058,0 | 833.508,0 | 825.277,0 | 861.999,0 |
| Shareholders' Equity | -741.649,0 | -840.273,0 | -661.232,0 | -544.830,0 | -469.062,0 |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | — | — | 166.859,0 | 270.030,0 | 377.520,0 |
| Current Assets | 815,0 | 57.368,0 | 166.859,0 | 270.030,0 | 377.520,0 |
| Current Liabilities | 742.464,0 | 898.058,0 | 833.508,0 | 825.277,0 | 861.999,0 |
{"event":"ticker_viewed","properties":{"ticker":"GCAN","listing_kind":"stock","pathname":"/stocks/gcan","exchange":"OTC","country":"US"}}